CurrentEmpire BluecrossPolicy 04-302

Local Delivery of Antimicrobial Agents (LDCA) — Coverage Criteria

Guideline for use of locally delivered chemotherapeutic/antimicrobial agents as adjunctive therapy in periodontal disease management; applies to dental providers and utilization review for Empire/Anthem lines of business.

Policy Summary

PayerEmpire Bluecross

PolicyLocal Delivery of Antimicrobial Agents (LDCA)

Policy CodePolicy 04-302

Change TypeNo material change

Effective Date01/01/2021

Next Review DateN/A

Key ActionObtain a current periodontal probing chart (within 12 months) after non-surgical periodontal therapy before considering LDCA.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

>= 5 mmpocket depth threshold

6w–6mhealing interval after SRP

12 monthsprobing chart recency

D4381, D4341, D4342, D4346, D4910, D4999, D6081CDT codes (info)

Coverage Criteria for Local Delivery of Antimicrobial Agents (LDCA)

Policy Summary

PayerEmpire Bluecross

PolicyLocal Delivery of Antimicrobial Agents (LDCA)

Policy CodePolicy 04-302

Change TypeNo material change

Effective Date01/01/2021

Next Review DateN/A

Key ActionObtain a current periodontal probing chart (within 12 months) after non-surgical periodontal therapy before considering LDCA.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

General prerequisites: Patient has undergone initial therapy with scaling and root planing (or periodontal surgery when applicable) and adequate time for healing has been allowed (6 weeks to 6 months). A current periodontal pocket probing chart (within the most recent 12 months) after completion of non-surgical periodontal therapy (D4341/D4342) and/or periodontal maintenance (D4910) is available.

Target lesion criteria: Local delivery of chemotherapeutic/antimicrobial agents is limited to isolated or refractory periodontal sites characterized by pocket depth >= 5 mm with persistent signs of inflammation, spontaneous bleeding or bleeding on probing, suppuration, and/or increasing clinical attachment loss or increasing pocket depth.>= 5 mm

Maintenance adjunct use: LDCA may be used as an adjunct during periodontal maintenance when localized recurrent and/or residual sites with inflammation are identified.

Coding and Relevant Clinical Thresholds

CDT codes listedCDT

D4381	Localized delivery of antimicrobial agents via a controlled release vehicle into diseased crevicular tissue per tooth.
D4341	Periodontal scaling and root planing, four or more teeth per quadrant.
D4342	Periodontal scaling and root planing, one to three teeth per quadrant.
D4346	Scaling in the presence of generalized moderate or severe gingival inflammation — full mouth, after oral exam.
D4910	Periodontal maintenance.
D4999	Unspecified periodontal procedure, by report.
D6081	Scaling and debridement in the presence of inflammation or mucositis of a single implant, including cleaning of the implant surfaces, without entry and closure: flap.

Periodontal pocket depth threshold (clinical key value)

Threshold>= 5 millimeters

Timeframe after SRP or surgery6 weeks to 6 months

Context for useConsidered for isolated or refractory periodontal sites after initial non-surgical therapy

Documentation requirementCurrent periodontal probing chart within 12 months required after non-surgical therapy/maintenance

Provider Actions, Documentation, and Billing Notes

Denial Risk

Linked non-covered services

When any service is performed in conjunction with or in preparation for a non-covered or denied service, all related services are also not covered or will be denied. Verify member contract benefits and coverage prior to providing services.

Affecting codes: D4381, D4341, D4342, D4346, D4910, D4999, D6081
Action: Confirm member-specific coverage before performing services or billing; services tied to a non-covered primary service may be denied
Documentation: Maintain clear records showing medical necessity and the relationship of adjunct procedures to covered services

Note

SRP before LDCA

Scaling and root planing (D4341/D4342) is the standard initial non-surgical periodontal therapy. LDCA (D4381) is considered an adjunctive therapy for persistent/refractory sites after appropriate non-surgical therapy has been performed and allowed to heal.

Codes: D4341, D4342 = scaling and root planing (standard initial therapy)
Codes: D4381 = localized delivery of antimicrobial agents — adjunctive for refractory sites only
Timing: LDCA may be considered 6 weeks to 6 months after non-surgical therapy or surgery if sites remain active

Documentation Required

Required documentation

A current periodontal probing chart (within the most recent 12 months) is required after completion of non-surgical periodontal therapy (D4341/D4342) and/or periodontal maintenance (D4910) to support the need for LDCA.

Required: Periodontal probing chart within 12 months following non-surgical therapy or maintenance
Use: Chart must document pocket depths and signs of inflammation to substantiate adjunctive LDCA use

Billing Rule

Coding and prior auth note

Coding note: CDT code D4381 is informationally listed here; inclusion does not guarantee coverage. Always verify member contract benefits prior to providing or billing for D4381 or related procedures.

Code of interest: D4381 — verify member coverage and any prior authorization requirements
Note: Informational coding does not equal authorization; check plan contract

Background

Local delivery of antimicrobial agents may be used as an adjunctive therapy for isolated or refractory periodontal pockets that persist after initial non-surgical therapy. Scaling and root planing is the standard initial treatment and most diseased sites will respond without adjunctive LDCA; LDCA is therefore generally reserved for sites that remain active or refractory (typically pockets >= 5 mm with signs of inflammation, bleeding on probing, suppuration, or progressive attachment loss) after allowing adequate healing time.

OpenPayer

Local Delivery of Antimicrobial Agents (LDCA) — Coverage Criteria

Coverage Criteria for Local Delivery of Antimicrobial Agents (LDCA)

Coding and Relevant Clinical Thresholds

Provider Actions, Documentation, and Billing Notes

Background

Definitions